Surmodics, Inc. (SRDX): Price and Financial Metrics

SRDX POWR Grades

• SRDX scores best on the Sentiment dimension, with a Sentiment rank ahead of 87.54% of US stocks.
• The strongest trend for SRDX is in Quality, which has been heading down over the past 179 days.
• SRDX ranks lowest in Growth; there it ranks in the 1st percentile.

SRDX Stock Summary

• With a price/earnings ratio of 358.98, Surmodics Inc P/E ratio is greater than that of about 98.28% of stocks in our set with positive earnings.
• Price to trailing twelve month operating cash flow for SRDX is currently 48.28, higher than 89.24% of US stocks with positive operating cash flow.
• Over the past twelve months, SRDX has reported earnings growth of -354.41%, putting it ahead of merely 5.55% of US stocks in our set.
• Stocks that are quantitatively similar to SRDX, based on their financial statements, market capitalization, and price volatility, are ARDX, SMCI, CLVS, FBIO, and TVTX.
• Visit SRDX's SEC page to see the company's official filings. To visit the company's web site, go to www.surmodics.com.

SRDX Valuation Summary

• In comparison to the median Healthcare stock, SRDX's price/earnings ratio is 1344.93% higher, now standing at 527.4.
• SRDX's price/sales ratio has moved down 31.7 over the prior 243 months.
• SRDX's price/sales ratio has moved down 31.7 over the prior 243 months.

Below are key valuation metrics over time for SRDX.

SRDX Growth Metrics

The 5 year revenue growth rate now stands at 51.24%.
• Its 4 year net income to common stockholders growth rate is now at -23.08%.
• The 3 year net income to common stockholders growth rate now stands at -121.62%.

SRDX's revenue has moved up $15,660,000 over the prior 34 months.

The table below shows SRDX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	105.842	12.633	1.699
2021-09-30	105.136	15.389	4.237
2021-06-30	103.708	15.814	1.58
2021-03-31	106.718	24.498	7.326
2020-12-31	94.545	10.649	0.701
2020-09-30	94.864	14.01	1.123

SRDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SRDX has a Quality Grade of B, ranking ahead of 94.57% of graded US stocks.
• SRDX's asset turnover comes in at 0.604 -- ranking 71st of 186 Medical Equipment stocks.
• MMSI, POAI, and OSUR are the stocks whose asset turnover ratios are most correlated with SRDX.

The table below shows SRDX's key quality metrics over time.